Zeitschrift für Orthomolekulare Medizin, Table of Contents Zeitschrift für Orthomolekulare Medizin 2025; 23(04): 24-25DOI: 10.1055/a-2717-6471 Forum | Leserbrief Hochdosis-Vitamin-C-Therapie bei Chronischer Lyme-Disease (CLD) Authors Contributor(s): Michael Kramer Uwe Gröber Thomas Welt Recommend Article Abstract Buy Article(opens in new window) Full Text References Literatur 1 Gröber U, Kramer M, Schütz B, Welt T. Aktuelle integrative und supportive Therapieoptionen bei Post-Treatment Lyme Disease Syndrome (PTLDS) und Chronischer Lyme-Disease (CLD), Teil 2: Hochdosis-Vitamin-C-Therapie (HDVC-Therapie) und antimikrobielle photodynamische Therapie (aPDT) bei Chronic Lyme Disease (CLD). OM – Zs f Orthomol 2025; 23: 18-29 2 Tichauer C, Corroon J, Fain R. et al. High dose intravenous vitamin C for lyme disease: a safety and tolerability study with an exploratory assessment of treatment efficacy. Medical Research Archives [S. l.]. 2024 v. 12. ISSN 2375-1924 3 Klimant E, Wright H, Rubin D. et al. Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach. Curr Oncol 2018; 25: 139-148 4 Mir W, Khan A, Amin MK. et al. Intravenous vitamin C as an adjunct to standard therapy in pancreatic ductal adenocarcinoma: A systematic review of clinical trials. J Clin Oncol 2025; 43: e16396 5 Zasowska-Nowak A, Nowak PJ, Ciałkowska-Rysz A. High-Dose Vitamin C in Advanced-Stage Cancer Patients. Nutrients 2021; 13: 735